Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ferric carboxymaltose on hypophosphatemia, hyperphosphaturia, and vitamin D supplementation in moderate iron deficiency anemia
TCTR20260630005Phase 4Completed
- Sponsor
- Nemani sai Manasa
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Nemani sai Manasa. Started Oct 2024; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on TCTR20260630005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260630005.